How CMV Drives Aging in HIV Patients—And What We Can Do About It

Cytomegalovirus (CMV), a virus that infects most people with HIV, accelerates aging and inflammation even when HIV is suppressed by medication. Recent studies show that antiviral drugs and vaccines may reverse some of this damage, …

35 Early
Design 4
Sample 2
Peer Review 13
Replication 7
Transparency 9

Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies.

Exosomes are secreted tiny organelles that are single-membrane enclosed and can perform a broad spectrum of functions upon release, such as the reorganization of extracellular matrix and communication with other cells through the release of …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Fenofibrate targets PPARα-CPT1C axis to reverse aging by regulating lipid metabolism and mitochondrial function.

Aging poses a growing global health burden, creating an urgent need for effective interventions. This study reveals that fenofibrate, a clinically approved drug for hyperlipidemia, exerts significant anti-aging effects by targeting fundamental aging processes. We …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Can a longevity protein protect Parkinson's patients from memory loss?

A protein that naturally extends lifespan might protect Parkinson's patients' thinking and memory, pointing to new treatments.

A protein called klotho, known to extend lifespan and boost brain function, appears to protect people with Parkinson's disease from cognitive decline—at least in genetic studies and mouse models. Researchers found that higher klotho levels …

53 Promising
Design 11
Sample 10
Peer Review 17
Replication 5
Transparency 10

HIV Drug Shows Promise for Slowing Biological Aging in Healthy Adults

Researchers tested whether an FDA-approved HIV medication (tenofovir alafenamide) could slow aging in healthy people by suppressing harmful retrotransposons. Over 12 weeks, the drug showed measurable reductions in epigenetic aging markers, but this is preliminary …

29 Early
Design 6
Sample 8
Peer Review 3
Replication 5
Transparency 7

Two Repurposed Drugs Trigger Cellular Stress Responses That Extend Lifespan in Worms

Two common drugs might slow aging by triggering cells' defense systems—but we need to test this claim in humans first.

Researchers found that terbinafine (an antifungal) and miglustat (a diabetes drug) activate mitochondrial stress responses that extended lifespan and improved health markers in C. elegans worms and human cells. The discovery suggests these existing drugs …

44 Early
Design 6
Sample 9
Peer Review 15
Replication 5
Transparency 9

AI System Identifies 500+ Aging-Slowing Interventions Hidden in Existing Data

Researchers used AI agents to reanalyze millions of existing molecular datasets (methylation and RNA sequencing) through the lens of aging clocks, discovering over 500 interventions that appear to reduce biological age—including drugs like ouabain and …

48 Early
Design 10
Sample 15
Peer Review 5
Replication 7
Transparency 11